ARAracely Suggey Guerra Rentería

Aracely Suggey Guerra Rentería

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aracely Suggey Guerra Rentería has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Estudios del agua. Un enfoque transdisciplinar

    by Aida Alejandra Guerrero de León, Aída Lucía Fajardo Montiel, Alberto Daniel Rocha Muñoz, Aldo Antonio Castañeda Villanueva, Amelia Nayeli López Cerpa, Ana Eduwiges del Rosario Ortiz Medina, Anahí Arreaga Cancino, Angélica de Jesús Cenceña Altamirano, Antonio Sánchez Sierra, Antonio Velázquez Ruíz, et al.

    El primer Encuentro Transdisciplinar de Estudios del Agua en México a cargo de ITRANS de la universidad de Guadalajara, fue un espacio de convergencia entre aquellos que buscaban soluciones ante los desafíos hídricos actuales donde promovieron el diálogo transdisciplinar y transformaron la investigación en acción. Los resultados, reflexiones y propuestas se reúnen en este libro con una reflexión crítica y creativa que se mueve entre el análisis académico y el compromiso ético con el entorno estructurado en tres secciones temáticas: Tecnología e innovación hídrica, Gobernanza y derechos humanos del agua, y los Recursos hídricos y calidad de agua.

  • Assessment of the Relationship between Clinical Variants of Psoriasis and Killer Immunoglobulin-like Receptor (KIR) Genes: A Systematic Review with Meta-analysis

    by José Macías-Barragán, Margarita Montoya-Buelna, Moisés Enciso-Vargas, Liliana Alvarado-Ruíz, Edén Oceguera-Contreras, Aracely Suggey Guerra-Renteria, Omar Graciano-Machuca

    Psoriasis (Ps) is an autoimmune dermatosis. Previous studies have shown an association between KIR genes and susceptibility to some clinical variants of Ps. Therefore, we conducted an exhaustive systematic review with meta-analysis to evaluate the relationship between KIR genes and susceptibility to clinical variants of Ps in the overall population and according to ethnicity. According to PRISMA guidelines, we performed a systematic review through PubMed and Web of Science to identify relevant available scientific publications about KIR genes and Ps. The quality of the studies was evaluated using the Newcastle-Ottawa scale. Odds ratios (OR) and 95% confidence intervals (95%CI) were estimated using random and fixed effect models for the analyzed genes. Heterogeneity was tested using Cochran's Q-Statistic and I2, and the risk of bias was tested using the Begg test and Egger linear regression. A total of 10 case-control studies were included, comprising a variable number of KIR typified genes and psoriasis vulgaris (PsV) as the main clinical variant studied. In the total pooled results, the KIR2DS1 gene (OR = 1.518, p = .010, 95%CI: 1.105 to 2.086) was related to higher susceptibility to PsV, while the KIR2DS4 (OR = 0.563, p = .005, 95%CI: 0.376 to 0.842) and KIR3DL1 (OR = 0.602, p = .040, 95%CI: 0.370 to 0.977) genes were related to protection against PsV. This meta-analysis demonstrates that subjects that carry the KIR2DS1 gene could have a potential risk factor for the development of PsV. Conversely, KIR2DS4 and 3DL1 genes appear to confer protection against PsV.


  • Comments on “Killer immunoglobulin‐like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease”

    by Itzel Viridiana Reyes‐Pérez, Moisés Enciso‐Vargas, José Macías‐Barragán, Araceli Suggey Guerra‐Rentería, Omar Graciano‐Machuca

    In 2016, López‐Hernández et al. published an interesting article titled Killer Immunoglobulin‐like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease (1). In this article, the authors found and reported positive associations between KIR2DL5, KIR2DS1, KIR2DS5 and KIR3DS1 with Inflammatory Bowel Disease (IBD) susceptibility, KIR2DS1 and KIR2DS5 with Crohn's Disease (CD) susceptibility, and KIR2DL5, KIR2DS1 and KIR2DS5 with Ulcerative Colitis (UC) susceptibility.